SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Lintermans, K. Van Asten, H. Wildiers, A. Laenen, R. Paridaens, C. Weltens, J. Verhaeghe, D. Vanderschueren, A. Smeets, E. Van Limbergen, K. Leunen, M. R. Christiaens, P. Neven, A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI, Breast Cancer Research and Treatment, 2014, 146, 1, 109

    CrossRef

  2. 2
    Daniel Wendling, Hélène Letho-Gyselinck, Xavier Guillot, Clément Prati, Xavier Pivot, Arthralgia and aromatase inhibitors, Joint Bone Spine, 2014, 81, 2, 187

    CrossRef

  3. 3
    Daniel Wendling, Hélène Letho-Gyselinck, Xavier Guillot, Clément Prati, Xavier Pivot, Arthralgies et anti-aromatases, Revue du Rhumatisme, 2014, 81, 2, 194

    CrossRef

  4. 4
    Francoise Laroche, Joël Coste, Terkia Medkour, Paul Henri Cottu, Jean-Yves Pierga, Jean-Pierre Lotz, Karine Beerblock, Christophe Tournigand, Xavier Declèves, Patricia de Cremoux, Didier Bouhassira, Serge Perrot, Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study, The Journal of Pain, 2014, 15, 3, 293

    CrossRef

  5. 5
    Ora Singer, Tessa Cigler, Anne B. Moore, Alana B. Levine, Huong T. Do, Lisa A. Mandl, Hypovitaminosis D is a Predictor of Aromatase Inhibitor Musculoskeletal Symptoms, The Breast Journal, 2014, 20, 2
  6. 6
    Temitope Olufade, Lisa Gallicchio, Ryan MacDonald, Kathy J. Helzlsouer, Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors, Supportive Care in Cancer, 2014,

    CrossRef